Conexeu Sciences

Conexeu Sciences is committed to a rigorous, science-led approach to tissue regeneration. It's what we like to call, Architecting Bioregeneration™.

[Conexeu Sciences @conexeusciences]

This is Architecting Bioregeneration™

----
CXU™ is an investigational device candidate; it has not been cleared or approved by the FDA. Preclinical concept; not predictive of clinical outcomes.

$CNXU #AestheticMedicine #Bioregeneration #ECM #Biotech #MedTech

[Conexeu Sciences @conexeusciences]

Conexeu $CNXU today provided an update on the regulatory and manufacturing program supporting its planned U.S. Food and Drug Administration (“FDA”) 510(k) premarket notification for Ten Minute Tissue™
https://t.co/W30ydO0J8W

[Conexeu Sciences @conexeusciences]

For decades, implant-based breast reconstruction has relied on permanent prosthetic volume.

We think there's a different question worth asking: could an engineered scaffold be designed to support host-tissue interaction and remodeling as part of reconstruction?” $CNXU #Biotech

[Conexeu Sciences @conexeusciences]

Our Chief Medical Officer, Brian Pilcher, PhD, joined Ana Reisdorf, MS, RD on the GLP-1 Hub podcast to unpack what's actually happening beneath the surface for patients on GLP-1s
$CNXU #Glp1 #biotech
https://t.co/AVmZukYleF

[Conexeu Sciences @conexeusciences]

Congratulations to our co-founder and Chief Scientific Officer, Dr. Claudia Chavez-Munoz, MD,PhD for her feature in Medical Design & Outsourcing!
$CNXU #biotech #RegenerativeMedicine #MedTech #Bioprinting #WomenInSTEM

https://t.co/bjOTIVv3At

[Conexeu Sciences @conexeusciences]

Conexeu Sciences $CNXU is pleased to announce its participation in the following investor and industry conferences during September and October 2026.
Read below for full schedule:

https://t.co/VjBtEZAva8

[Conexeu Sciences @conexeusciences]

Our B.R.E.A.S.T.™ device candidate is being developed as a patient-specific scaffold designed for the mechanical environment of breast reconstruction, with the long-term goal of reducing or eliminating reliance on a permanent breast implant.
$CNXU
Watch:
https://t.co/rEj0dz9Okw

[Conexeu Sciences @conexeusciences]

Conexeu (Nasdaq $CNXU ) believes a new category is emerging within medical aesthetics centered on regenerative tissue restoration.

Read Full Release: https://t.co/Aq1iFi2MUs

#Conexeu #RegenerativeMedicine #Aesthetics #WoundCare
#Biotech #TissueRegeneration

[Conexeu Sciences @conexeusciences]

New podcast feature: Conexeu Sciences (Nasdaq $CNXU) President and CEO Miles Harrison joined @ChrisJVersace on @TheStreetPro 's Stocks & Markets Podcast to talk regenerative medicine's next leap. #biotech #regenerativemedicine https://t.co/HgPlYRqArR

[Conexeu Sciences @conexeusciences]

Conexeu Sciences (Nasdaq $CNXU) is aiming CXU™ at the largest unclaimed frontier in injectable aesthetics: restoring body fullness at a scale today's fillers were never built to reach. https://t.co/5H6UQTypf3

[Investor TV @_investortv]

CEO Miles Harrison discusses Conexeu Sciences' ( $CNXU ) expansion into regenerative aesthetics, the potential of its patented CXU™ platform, its collaboration with the Wake Forest Institute for Regenerative Medicine (WFIRM), and more.

Watch: https://t.co/Fjs6jM61QQ

[Conexeu Sciences @conexeusciences]

Conexeu Sciences (@Nasdaq $CNXU) Completes 12-Month Preclinical P.R.O.O.F Study, Supporting Its Intended Move Into the $11 Billion Medical Aesthetics Market as a Platform. Read More:
https://t.co/BsZCxOle2D

[Conexeu Sciences @conexeusciences]

Join Conexeu Sciences (NASDAQ: $CNXU ) President & CEO Miles Harrison for an exclusive @_investortv investor webinar moderated by Global One Media's Moneer Barazi.

Monday, June 30 | 11:00 AM EST
Reserve Your Spot: https://t.co/JrzikzkNdJ

[Conexeu Sciences @conexeusciences]

Conexeu Sciences Inc. (Nasdaq: $CNXU ) announced the opening of its new research and development facility at adMare BioInnovations' M4 Innovation Centre in Vancouver, Canada, a purpose-built hub for leading life sciences companies.

Read More: https://t.co/gw5kUWjXos

[Conexeu Sciences @conexeusciences]

Architecture shapes space for human life.

It is thoughtful. Intentional. Purposeful.

At its best, architecture makes life more human by creating structures that support, restore, and inspire.

At Conexeu, we believe the human body deserves the same discipline.

[Conexeu Sciences @conexeusciences]

A defining moment. A new chapter. A bold vision for the future of bioregeneration.

Last week, we officially unveiled Conexeu Sciences Inc. (@Nasdaq : $CNXU ) to the world, marking the beginning of a new era in how we think about regeneration.

[Conexeu Sciences @conexeusciences]

Conexeu (Nasdaq: $CNXU) Expands Board, Executive, and Advisory Leadership With Five Appointments Post Nasdaq Listing
https://t.co/ZVUMcZODic

[Nasdaq Exchange @NasdaqExchange]

Welcoming @conexeusciences [CNXU] to the @Nasdaq Closing Bell. https://t.co/ak07yYeJxP

[Conexeu Sciences @conexeusciences]

Conexeu Sciences (Nasdaq: $CNXU) today announced progress in manufacturing scale up and standardized formulation methods with its contract development and manufacturing organization (“CDMO”) for its lead CXU™ wound care device candidate.

https://t.co/PVXXcn8UeV

[Conexeu Sciences @conexeusciences]

Conexeu (Nasdaq: $CNXU ) will ring the Nasdaq Bell on Wednesday, June 10, 2026, at the Nasdaq MarketSite in New York City in celebration of its recent public listing and the commencement of trading under the ticker symbol "CNXU." Read Full Release:
https://t.co/BuliMTB3Hp